Business Context and Reporting Period
This Form 8-K is filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on January 3, 2019. The report announces the financial performance for the fourth fiscal quarter ended December 31, 2018. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing references a press release (Exhibit 99.1) containing these details but does not reproduce the figures within the body of the 8-K text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only indicates that a press release detailing the fourth-quarter results has been issued.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or unusual items. It explicitly states that the information in Item 2.02 and the attached press release shall not be deemed "filed" for purposes of Section 18 of the Exchange Act nor incorporated by reference into other filings, except as expressly set forth.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (Press Release dated January 3, 2019), as they are not listed in this summary text.
- Confirm the registrant name is MRI Interventions, Inc., noting the discrepancy with the "Clearpoint Neuro, Inc." label in the request metadata.
- Check for any subsequent filings or updates regarding the fourth-quarter 2018 performance.